Substituted heterocycles as Janus kinase inhibitors
US8513270B2 · kind B2 · utility
82Cited by
6References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2007 |
| Grant date | Aug 20, 2013 |
| Priority date | — |
| Expiry date | Aug 12, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/437
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides substituted tricyclic heteroaryl compounds, including, for example, pyridoindoles, pyrimidinoindoles and triazinoindoles that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases such as immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.